BIOR Annual CFI
$2.44 M
+$3.23 M+408.46%
31 December 2023
Summary:
As of January 23, 2025, BIOR annual cash flow from investing activities is $2.44 million, with the most recent change of +$3.23 million (+408.46%) on December 31, 2023. During the last 3 years, it has risen by +$7.39 million (+149.41%). BIOR annual CFI is now -95.62% below its all-time high of $55.83 million, reached on December 1, 2018.BIOR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOR Quarterly CFI
-$19.00 K
+$161.00 K+89.44%
30 September 2024
Summary:
As of January 23, 2025, BIOR quarterly cash flow from investing activities is -$19.00 thousand, with the most recent change of +$161.00 thousand (+89.44%) on September 30, 2024. Over the past year, it has dropped by -$18.00 thousand (-1800.00%). BIOR quarterly CFI is now -100.19% below its all-time high of $9.85 million, reached on June 1, 2019.BIOR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOR TTM CFI
$5.28 M
-$18.00 K-0.34%
30 September 2024
Summary:
As of January 23, 2025, BIOR TTM cash flow from investing activities is $5.28 million, with the most recent change of -$18.00 thousand (-0.34%) on September 30, 2024. Over the past year, it has increased by +$5.37 million (+5482.65%). BIOR TTM CFI is now -71.48% below its all-time high of $18.50 million, reached on June 1, 2019.BIOR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOR Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +408.5% | -1800.0% | +5482.6% |
3 y3 years | +149.4% | +94.4% | +570.6% |
5 y5 years | -95.6% | +97.7% | -68.1% |
BIOR Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +296.7% | -100.6% | +94.4% | -3.3% | +524.7% |
5 y | 5-year | -85.2% | +149.4% | -100.6% | +99.1% | -68.1% | +206.7% |
alltime | all time | -95.6% | +149.4% | -100.2% | +99.1% | -71.5% | +206.7% |
Biora Therapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$19.00 K(-89.4%) | $5.28 M(-0.3%) |
June 2024 | - | -$180.00 K(-106.0%) | $5.29 M(-3.0%) |
Mar 2024 | - | $3.00 M(+21.7%) | $5.45 M(+123.3%) |
Dec 2023 | $2.44 M(-408.5%) | $2.47 M(<-9900.0%) | $2.44 M(-2592.9%) |
Sept 2023 | - | -$1000.00(-94.7%) | -$98.00 K(-62.5%) |
June 2023 | - | -$19.00 K(+216.7%) | -$261.00 K(-42.8%) |
Mar 2023 | - | -$6000.00(-91.7%) | -$456.00 K(-42.4%) |
Dec 2022 | -$792.00 K(-36.2%) | -$72.00 K(-56.1%) | -$792.00 K(+55.6%) |
Sept 2022 | - | -$164.00 K(-23.4%) | -$509.00 K(-34.5%) |
June 2022 | - | -$214.00 K(-37.4%) | -$777.00 K(-30.7%) |
Mar 2022 | - | -$342.00 K(-262.1%) | -$1.12 M(-9.7%) |
Dec 2021 | -$1.24 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | - | $211.00 K(-148.8%) | -$1.24 M(-64.2%) |
Sept 2021 | - | -$432.00 K(-22.6%) | -$3.47 M(-20.1%) |
June 2021 | - | -$558.00 K(+20.5%) | -$4.34 M(+0.6%) |
Mar 2021 | - | -$463.00 K(-77.0%) | -$4.31 M(-12.8%) |
Dec 2020 | -$4.94 M(-129.9%) | -$2.01 M(+54.4%) | -$4.94 M(+32.2%) |
Sept 2020 | - | -$1.30 M(+144.7%) | -$3.74 M(+3.9%) |
June 2020 | - | -$533.00 K(-51.3%) | -$3.60 M(-153.0%) |
Mar 2020 | - | -$1.09 M(+35.4%) | $6.79 M(-58.9%) |
Dec 2019 | $16.52 M(-70.4%) | -$808.00 K(-30.6%) | $16.52 M(-4.7%) |
Sept 2019 | - | -$1.16 M(-111.8%) | $17.33 M(-6.3%) |
June 2019 | - | $9.85 M(+14.0%) | $18.50 M(+114.0%) |
Mar 2019 | - | $8.64 M | $8.64 M |
Dec 2018 | $55.83 M | - | - |
FAQ
- What is Biora Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Biora Therapeutics?
- What is Biora Therapeutics annual CFI year-on-year change?
- What is Biora Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Biora Therapeutics?
- What is Biora Therapeutics quarterly CFI year-on-year change?
- What is Biora Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Biora Therapeutics?
- What is Biora Therapeutics TTM CFI year-on-year change?
What is Biora Therapeutics annual cash flow from investing activities?
The current annual CFI of BIOR is $2.44 M
What is the all time high annual CFI for Biora Therapeutics?
Biora Therapeutics all-time high annual cash flow from investing activities is $55.83 M
What is Biora Therapeutics annual CFI year-on-year change?
Over the past year, BIOR annual cash flow from investing activities has changed by +$3.23 M (+408.46%)
What is Biora Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BIOR is -$19.00 K
What is the all time high quarterly CFI for Biora Therapeutics?
Biora Therapeutics all-time high quarterly cash flow from investing activities is $9.85 M
What is Biora Therapeutics quarterly CFI year-on-year change?
Over the past year, BIOR quarterly cash flow from investing activities has changed by -$18.00 K (-1800.00%)
What is Biora Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BIOR is $5.28 M
What is the all time high TTM CFI for Biora Therapeutics?
Biora Therapeutics all-time high TTM cash flow from investing activities is $18.50 M
What is Biora Therapeutics TTM CFI year-on-year change?
Over the past year, BIOR TTM cash flow from investing activities has changed by +$5.37 M (+5482.65%)